Table 5.

Distribution of cases and controls by 4-ABP-Hb adducts (detectable/not detectable) in women (n= 153)

Detectable 4-ABP-Hb adducts, n (%)OR (95% CI)
Controls (n = 83)29 (35)
Lung cancer (n = 16)9 (56)2.27 (0.66-7.87)
Bladder cancer (n = 10)6 (60)2.54 (0.56-11.60)
Leukemias (n = 29)16 (55)2.77 (1.06-7.20)
Oral cancer (n = 10)6 (60)3.06 (0.70-13.37)
COPD or emphysema deaths (n = 5)2 (40)0.89 (0.11-6.90)
  • NOTE: Data were adjusted for country, age at recruitment, smoking status, cotinine, and fruit and vegetable intake.

    Abbreviations: OR, odds ratio; COPD, chronic obstructive pulmonary disease.